(Q50584454)

16 March 2018

title

Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. (English)

1 reference

16 March 2018

1 reference

1 reference

Kozhikode V Narayanan Menon

1

1 reference

16 March 2018

John J Poterucha

2

1 reference

16 March 2018

Omer M El-Amin

3

1 reference

16 March 2018

Lawrence J Burgart

4

1 reference

16 March 2018

Walter K Kremers

5

1 reference

16 March 2018

Charles B Rosen

6

1 reference

16 March 2018

Russell H Wiesner

7

1 reference

16 March 2018

Michael Charlton

8

1 reference

16 March 2018

publication date

1 July 2002

1 reference

16 March 2018

published in

Liver Transplantation

1 reference

16 March 2018

volume

8

1 reference

16 March 2018

issue

7

1 reference

16 March 2018

page(s)

623-629

1 reference

16 March 2018

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Predictors of patient and graft survival following liver transplantation for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

The influence of hepatitis C virus genotypes on the outcome of liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Reinfection of liver graft by hepatitis C virus after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Graft loss following liver transplantation in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.33968

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.33968

1 reference

16 March 2018

release_lpx67nqulfcm7i34ldodpaely4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lpx67nqulfcm7i34ldodpaely4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 March 2018